Dexco S.A.

Informe acción BOVESPA:DXCO3

Capitalización de mercado: R$4.7b

Dexco Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Los beneficios de Dexco han disminuido a una tasa media anual de -32.7%, mientras que en la industria Forestry los beneficios disminuyeron en un 0.9% anualmente. Los ingresos han ido creciendo a una tasa media de 2.4% al año. La rentabilidad financiera de Dexco es de 0.9%, y sus márgenes netos son de 0.01%.

Información clave

-32.68%

Tasa de crecimiento de los beneficios

-33.13%

Tasa de crecimiento del BPA

Crecimiento de la industria Forestry 45.90%
Tasa de crecimiento de los ingresos2.42%
Rentabilidad financiera0.87%
Margen neto0.014%
Próxima actualización de resultados06 May 2026

Actualizaciones de resultados anteriores recientes

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

Recent updates

DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside

Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.

DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook

Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.

DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside

Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.

DXCO3: Planned Stock Split Will Support Positive Long Term Outlook

Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).

DXCO3: Future Stock Split Will Support A More Attractive Share Repricing

Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).

DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside

Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.

DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook

Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

DXCO3: Future Margins And Stock Split Plan Will Support Upside

Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.

Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar

Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar

DXCO3: Stronger Future Margins And Investor Day May Drive Upside

Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Urbanization Trends And Digital Platforms Will Expand Market Reach

With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.

Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
User avatar

New Ceramic Tiles Factory In Botucatu Will Improve Future Operations

Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.

Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden

Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden

Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

Is Dexco (BVMF:DXCO3) A Risky Investment?

Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

Is Dexco (BVMF:DXCO3) A Risky Investment?

Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?

Returns At Dexco (BVMF:DXCO3) Are On The Way Up

Jun 22
Returns At Dexco (BVMF:DXCO3) Are On The Way Up

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

May 31
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Desglose de ingresos y gastos

Cómo gana y gasta dinero Dexco. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

BOVESPA:DXCO3 Ingresos, gastos y beneficios (BRL Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Dec 258,24911,5300
30 Sep 258,2161111,5440
30 Jun 258,3271931,5950
31 Mar 258,2012581,5770
31 Dec 248,2351721,5450
30 Sep 248,1193371,5330
30 Jun 247,6495421,4710
31 Mar 247,6076021,4750
31 Dec 237,3837901,4280
30 Sep 237,4158121,3810
30 Jun 237,8086681,3920
31 Mar 238,0686801,4150
31 Dec 228,4877561,4590
30 Sep 228,7571,1281,4920
30 Jun 228,7731,2291,4460
31 Mar 228,5331,7761,3370
31 Dec 218,1701,7251,3100
30 Sep 217,8131,4461,1640
30 Jun 217,4141,3151,1270
31 Mar 216,4865741,0650
31 Dec 205,8804541,0370
30 Sep 205,4724371,0180
30 Jun 205,0033419900
31 Mar 205,1014349800
31 Dec 195,0124069480
30 Sep 194,789-219190
30 Jun 194,9933279290
31 Mar 195,0164259190
31 Dec 184,9494328990
30 Sep 184,7896588690
30 Jun 184,2963658250
31 Mar 184,0452238070
31 Dec 173,9911858010
30 Sep 173,9171257850
30 Jun 173,864727610
31 Mar 173,960477610
31 Dec 163,910247520
30 Sep 163,836507570
30 Jun 163,911487670
31 Mar 163,863857540
31 Dec 153,9631837550
30 Sep 154,0482217310
30 Jun 154,0642757160

Ingresos de calidad: DXCO3 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(0.01%) de DXCO3 son inferiores a los del año pasado (2.1%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de DXCO3 han disminuido en un 32.7% al año en los últimos 5 años.

Acelerando crecimiento: DXCO3 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: DXCO3 tuvo un crecimiento negativo de los beneficios (-99.3%) durante el año pasado, lo que dificulta la comparación con la media de la industria Forestry (-7.2%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de DXCO3 (0.9%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/02 18:01
Precio de las acciones al final del día2026/04/30 00:00
Beneficios2025/12/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Dexco S.A. está cubierta por 16 analistas. 11 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Guilherme RositoBofA Global Research
Rafael BarcellosBradesco S.A. Corretora de Títulos e Valores Mobiliários
Carlos Palhares SequeiraBTG Pactual